These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis]. Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520 [TBL] [Abstract][Full Text] [Related]
26. Bleomycin-induced pulmonary fibrosis is attenuated by an antibody against KL-6. Xu L; Yang D; Zhu S; Gu J; Ding F; Bian W; Rong Z; Shen C Exp Lung Res; 2013 Aug; 39(6):241-8. PubMed ID: 23672275 [TBL] [Abstract][Full Text] [Related]
27. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice. Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852 [TBL] [Abstract][Full Text] [Related]
28. Empagliflozin and Dulaglutide are Effective against Obesity-induced Airway Hyperresponsiveness and Fibrosis in A Murine Model. Park HJ; Han H; Oh EY; Kim SR; Park KH; Lee JH; Park JW Sci Rep; 2019 Oct; 9(1):15601. PubMed ID: 31666643 [TBL] [Abstract][Full Text] [Related]
29. Pyrrolidinedithiocarbamate attenuates bleomycin-induced pulmonary fibrosis in rats: Modulation of oxidative stress, fibrosis, and inflammatory parameters. Zaafan MA; Zaki HF; El-Brairy AI; Kenawy SA Exp Lung Res; 2016; 42(8-10):408-416. PubMed ID: 27797599 [TBL] [Abstract][Full Text] [Related]
30. Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway. Ruan H; Lv Z; Liu S; Zhang L; Huang K; Gao S; Gan W; Liu X; Zhang S; Helian K; Li X; Zhou H; Yang C J Pharm Pharmacol; 2020 Jan; 72(1):44-55. PubMed ID: 31659758 [TBL] [Abstract][Full Text] [Related]
31. Beneficial effects of early (but not late) intervention of heme oxygenase-1 on bleomycin-induced pulmonary fibrosis in mice. Jin C; Zhou D; Lv F Respir Physiol Neurobiol; 2011 Feb; 175(2):239-46. PubMed ID: 21111848 [TBL] [Abstract][Full Text] [Related]
33. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition. Gao L; Jiang D; Geng J; Dong R; Dai H Exp Physiol; 2019 Dec; 104(12):1942-1951. PubMed ID: 31535412 [TBL] [Abstract][Full Text] [Related]
34. Epicatechin protective effects on bleomycin-induced pulmonary oxidative stress and fibrosis in mice. Shariati S; Kalantar H; Pashmforoosh M; Mansouri E; Khodayar MJ Biomed Pharmacother; 2019 Jun; 114():108776. PubMed ID: 30903918 [TBL] [Abstract][Full Text] [Related]
35. The combination of ursolic acid and empagliflozin relieves diabetic nephropathy by reducing inflammation, oxidative stress and renal fibrosis. Wu X; Li H; Wan Z; Wang R; Liu J; Liu Q; Zhao H; Wang Z; Zhang H; Guo H; Qi C; Jiao X; Li X Biomed Pharmacother; 2021 Dec; 144():112267. PubMed ID: 34624679 [TBL] [Abstract][Full Text] [Related]
36. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways. Ma WH; Li M; Ma HF; Li W; Liu L; Yin Y; Zhou XM; Hou G Life Sci; 2020 Jan; 241():117139. PubMed ID: 31809714 [TBL] [Abstract][Full Text] [Related]
37. Empagliflozin and Liraglutide Differentially Modulate Cardiac Metabolism in Diabetic Cardiomyopathy in Rats. Trang NN; Chung CC; Lee TW; Cheng WL; Kao YH; Huang SY; Lee TI; Chen YJ Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503985 [TBL] [Abstract][Full Text] [Related]
38. Effects of a leukotriene B4 receptor antagonist on bleomycin-induced pulmonary fibrosis. Izumo T; Kondo M; Nagai A Eur Respir J; 2009 Dec; 34(6):1444-51. PubMed ID: 19460787 [TBL] [Abstract][Full Text] [Related]
39. Antifibrotic effects of low dose SGLT2 Inhibition with empagliflozin in comparison to Ang II receptor blockade with telmisartan in 5/6 nephrectomised rats on high salt diet. Zeng S; Delic D; Chu C; Xiong Y; Luo T; Chen X; Gaballa MMS; Xue Y; Chen X; Cao Y; Hasan AA; Stadermann K; Frankenreiter S; Yin L; Krämer BK; Klein T; Hocher B Biomed Pharmacother; 2022 Feb; 146():112606. PubMed ID: 34968924 [TBL] [Abstract][Full Text] [Related]